Guidelines for generic substitution in the Netherlands
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: JAMA, Wafa (Royal Dutch Pharmacists Association (KNMP), Center for Information on Medicines, The Hague, Netherlands)
- Co-author(s): Grandia, Leonora (Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands)
In general, medications that passed bioequivalence testing should be substitutable to their generically equivalent when needed. However, for a variety of reasons this may not be the case and caution needs to be warranted. The Royal Dutch Pharmacists Association (KNMP) published guidelines for community pharmacists to help them to determine the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.